NCT05283720 2026-03-03A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin LymphomaGenmabPhase 2 Recruiting496 enrolled
NCT01087333 2026-02-17Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer TreatmentNational Institutes of Health Clinical Center (CC)Recruiting1,263 enrolled
NCT04775745 2026-02-13Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.Newave Pharmaceutical IncPhase 1 Recruiting60 enrolled
NCT01199562 2026-01-28Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell TransplantCity of Hope Medical CenterActive not recruiting153 enrolled
NCT05362773 2026-01-13A Study of MGD024 in Patients With Relapsed or Refractory Hematologic MalignanciesMacroGenicsPhase 1 Recruiting130 enrolled